Potassium voltage-gated channel subfamily Q member 2 (KCNQ2) and Potassium sodium-activated channel subfamily T member 2 (KCNT2) (KCNQ2/KCNT2)

KCNQ2 and KCNT2 are distinct potassium channel subunits that play critical roles in regulating the electrical excitability of neurons in the central nervous system (UniProt, PubMed). KCNQ2 (Kv7.2) is a voltage-gated channel that typically forms heteromers with KCNQ3 to produce the M-current, a slow-activating current that stabilizes the resting membrane potential and prevents repetitive action potential firing (NIH, PubMed). KCNT2 (Slick) is a sodium-activated potassium channel that modulates neuronal firing patterns in response to changes in intracellular sodium and chloride concentrations (PubMed, StatPearls). Mutations in either gene are major causes of severe neonatal-onset epilepsy and developmental and epileptic encephalopathy (DEE) (PubMed, NIH). While both are essential for maintaining proper neuronal balance and are targeted by anti-seizure medications like retigabine and quinidine, they belong to different protein families and do not form functional heteromeric complexes with each other (PubMed). KCNQ2-related disorders range from benign familial neonatal epilepsy to severe encephalopathy, whereas KCNT2 variants are primarily associated with early-onset developmental delays and seizures (PubMed). Therapeutic strategies for KCNQ2 often involve channel openers to restore the M-current, while KCNT2 gain-of-function mutations may require channel blockers (PubMed). Despite their shared clinical context in pediatric neurology, they represent independent molecular targets with unique pharmacological profiles (PubMed).

Other names

Kv7.2SlickKNa1.2SLO2.1EIEE7EIEE57BFNCBFNE

Drugs targeting KCNQ2, such as retigabine, typically act as positive allosteric modulators or openers to enhance the M-current and reduce neuronal firing (PubMed, NIH). For KCNT2, pharmacological strategies often involve the use of blockers like quinidine to mitigate gain-of-function mutations that cause excessive potassium efflux and subsequent neuronal dysfunction (PubMed).